» Articles » PMID: 3487457

Interferon-alpha/beta Enhances the Expression of Ly-6 Antigens on T Cells in Vivo and in Vitro

Overview
Journal Eur J Immunol
Date 1986 Jul 1
PMID 3487457
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Interferons (IFN) have been shown to modulate the expression of a number of cell surface antigens on macrophages and lymphocytes. Because such phenotypic alterations may be involved in the functional effects of IFN, it appears important to characterize further these alterations. In the present work, we evaluated the response to IFN of Ly-6-encoded molecules on murine T cells. Two types of Ly-6 antigens, Ly-6A and Ly-6C, normally present on minor subsets of mature T cells were studied. It was found that in vivo treatment of mice with the IFN inducer poly(I . C) or with purified IFN-alpha/beta resulted two days later in augmented expression of these antigens. Purified T cells cultured in vitro for 2 days in the presence of 5% serum from poly(I . C)-treated mice or of 10(4) units/ml IFN-alpha/beta also displayed dramatically increased (4-12-fold) amounts of Ly-6 antigens. Under the same conditions, the T cell markers Thy-1, Ly-1, Lyt-2 and MT4 were unaffected or slightly diminished while surface expression of H-2 or beta 2-microglobulin antigens was increased by only 10-36%. Therefore, poly(I . C)-induced or purified IFN interacts with resting T cells to selectively enhance Ly-6 antigen expression. This phenomenon was found to correlate functionally with increased proliferative response of the T cells, in presence of phorbol myristate acetate, to anti-Ly-6 antibodies cross-linked on their surface. Enhancement of Ly-6 antigen expression on T cells may thus play a role in IFN-mediated immunoregulation.

Citing Articles

A systematic survey of LU domain-containing proteins reveals a novel human gene, LY6A, which encodes the candidate ortholog of mouse Ly-6A/Sca-1 and is aberrantly expressed in pituitary tumors.

Liu D, Xu C, Liu Y, Ouyang W, Lin S, Xu A Front Med. 2023; 17(3):458-475.

PMID: 36928550 DOI: 10.1007/s11684-022-0968-4.


Heterogeneous RNA editing and influence of ADAR2 on mesothelioma chemoresistance and the tumor microenvironment.

Hariharan A, Qi W, Rehrauer H, Wu L, Ronner M, Wipplinger M Mol Oncol. 2022; 16(22):3949-3974.

PMID: 36221913 PMC: 9718120. DOI: 10.1002/1878-0261.13322.


Induction of T Cell Senescence by Cytokine Induced Bystander Activation.

Abbas A, Akbar A Front Aging. 2022; 2:714239.

PMID: 35821998 PMC: 9261416. DOI: 10.3389/fragi.2021.714239.


Intratumoural administration of an NKT cell agonist with CpG promotes NKT cell infiltration associated with an enhanced antitumour response and abscopal effect.

Prasit K, Ferrer-Font L, Burn O, Anderson R, Compton B, Schmidt A Oncoimmunology. 2022; 11(1):2081009.

PMID: 35712122 PMC: 9196710. DOI: 10.1080/2162402X.2022.2081009.


Follicular T cells are clonally and transcriptionally distinct in B cell-driven mouse autoimmune disease.

Akama-Garren E, van den Broek T, Simoni L, Castrillon C, van der Poel C, Carroll M Nat Commun. 2021; 12(1):6687.

PMID: 34795279 PMC: 8602266. DOI: 10.1038/s41467-021-27035-8.